These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7038879

  • 101. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N, Haustein UF, Barthelmes H.
    Z Arztl Fortbild (Jena); 1971 Jun 15; 65(12):581-5. PubMed ID: 4939579
    [No Abstract] [Full Text] [Related]

  • 102. Relationship between complement-fixing (hemolytic) antibodies to single-stranded and double-stranded DNA and the prognosis in systemic lupus erythematosus.
    Sasaki T, Kadono T, Endo F, Sekiguchi Y, Saito T, Arakawa M, Furuyama T, Yoshinaga K.
    Tohoku J Exp Med; 1982 Dec 15; 138(4):341-55. PubMed ID: 6984545
    [Abstract] [Full Text] [Related]

  • 103. Therapeutic potential (1).
    Zack DJ, Isenberg D.
    Lupus; 2008 Mar 15; 17(3):259-61. PubMed ID: 18372373
    [No Abstract] [Full Text] [Related]

  • 104. Cellular interactions and signalling defects in lupus (1).
    Zouali M, Mageed RA.
    Lupus; 2008 Mar 15; 17(3):236-40. PubMed ID: 18372368
    [No Abstract] [Full Text] [Related]

  • 105. [Circulating immune complexes in glomerulonephritis and systemic lupus erythematosus. Clinico-immunological correlations].
    Shishkin VI, Belendir ME, Pigareva NV, Klemina IK.
    Ter Arkh; 1981 Mar 15; 53(6):30-4. PubMed ID: 6456567
    [No Abstract] [Full Text] [Related]

  • 106. [Complement deficiency, immunocomplexes and lupus erythematosus].
    Vivanco Martínez F.
    Rev Clin Esp; 1987 Mar 15; 180(5):264-8. PubMed ID: 3602524
    [No Abstract] [Full Text] [Related]

  • 107. DNA/anti-DNA complexes: correlation of size and complement fixation.
    Waller SJ, Taylor RP, Wright EL, Morley KW, Johns M.
    Arthritis Rheum; 1981 May 15; 24(5):651-7. PubMed ID: 7236322
    [Abstract] [Full Text] [Related]

  • 108. Antinuclear antibodies and lupus: causes and consequences.
    Ehrenstein MR.
    Rheumatology (Oxford); 1999 Aug 15; 38(8):691-3. PubMed ID: 10501412
    [No Abstract] [Full Text] [Related]

  • 109. [Antibodies to DNA--an inventory of the current status].
    Wollina U.
    Dermatol Monatsschr; 1986 Aug 15; 172(7):381-6. PubMed ID: 3489646
    [No Abstract] [Full Text] [Related]

  • 110. Fc-receptor dysfunction in lupus.
    Krishnan L, Krishnan EC, Jewell WR.
    N Engl J Med; 1979 Jun 28; 300(26):1486-7. PubMed ID: 449890
    [No Abstract] [Full Text] [Related]

  • 111. [Colorimetric method of determining the interaction of sera from patients with systemic lupus erythematosus with native deoxyribonucleic acid].
    Tsebetsauer L, Gaĭzok O, Rovenski I, Zhitnian D.
    Vopr Med Khim; 1976 Jun 28; 22(5):716-9. PubMed ID: 65054
    [No Abstract] [Full Text] [Related]

  • 112. The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.
    Pisetsky DS, Shaffer R, Armstrong DD, Spencer DM.
    Clin Immunol; 2021 Oct 28; 231():108848. PubMed ID: 34492381
    [Abstract] [Full Text] [Related]

  • 113. Circulating Microparticle Double-Stranded Deoxyribonucleic Acid in Systemic Lupus Erythematosus.
    Tay SH, Lateef A, Lim YC, Ng IJ, Koh DR, Lim LH.
    Ann Acad Med Singap; 2016 Aug 28; 45(8):373-5. PubMed ID: 27683744
    [No Abstract] [Full Text] [Related]

  • 114. [Clinico-immunological parallels in systemic lupus erythematosus].
    Drampian FS, Aznaurian AV.
    Zh Eksp Klin Med; 1971 Aug 28; 11(1):101-4. PubMed ID: 5315376
    [No Abstract] [Full Text] [Related]

  • 115. Why the difference between B-DNA and Z-DNA?
    Stollar BD.
    Lupus; 1997 Aug 28; 6(3):327-8. PubMed ID: 9296781
    [No Abstract] [Full Text] [Related]

  • 116. Equilibrium theory for the binding of bivalent antibodies to regularly spaced sites on a DNA molecule.
    Wiegel FW, Goldstein B.
    Biopolymers; 1987 Feb 28; 26(2):297-314. PubMed ID: 3828476
    [No Abstract] [Full Text] [Related]

  • 117. Fc-receptor dysfunction in lupus.
    Cooper SM.
    N Engl J Med; 1979 Jun 28; 300(26):1486. PubMed ID: 449889
    [No Abstract] [Full Text] [Related]

  • 118. The clinical significance of antinuclear antibodies.
    Tan EM, Northway JD, Pinnas JL.
    Postgrad Med; 1973 Nov 28; 54(5):143-50. PubMed ID: 4126835
    [No Abstract] [Full Text] [Related]

  • 119. [Examination of antibodies against nucleoprotein using the "spot" test and its comparison with the usual antinuclear factor determination].
    Kratochvil F, Vlasín Z.
    Vnitr Lek; 1971 Dec 28; 17(12):1155-9. PubMed ID: 4944712
    [No Abstract] [Full Text] [Related]

  • 120. Hydralazine-induced lupus: yet another autoantibody!
    Pirmohamed M.
    Hum Exp Toxicol; 1996 Apr 28; 15(4):361-2. PubMed ID: 8845227
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.